Boehringer HIV drug helps some, says U.S. FDA staff (Reuter


Reuters - Boehringer Ingelheim Pharmaceutical
Inc.'s experimental HIV drug is effective in some
drug-resistant patients when used in combination with Abbott
Laboratories' Norvir, U.S. regulatory staff said in documents
released on Wednesday.

Read more...